These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30017637)

  • 1. Explaining the dynamics of tumor aggressiveness: At the crossroads between biology, artificial intelligence and complex systems.
    La Porta CAM; Zapperi S
    Semin Cancer Biol; 2018 Dec; 53():42-47. PubMed ID: 30017637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexity in cancer stem cells and tumor evolution: Toward precision medicine.
    La Porta CAM; Zapperi S
    Semin Cancer Biol; 2017 Jun; 44():3-9. PubMed ID: 28254567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNAs regulate tumor cell plasticity.
    Liu B; Sun L; Song E
    Sci China Life Sci; 2013 Oct; 56(10):886-90. PubMed ID: 24091685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Special Issue "Cancer Stem Cells: Impact on Treatment".
    Skvortsova I
    Semin Cancer Biol; 2018 Dec; 53():iii-iv. PubMed ID: 30509407
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer stem cells: recent developments and future prospects.
    Singh SR
    Cancer Lett; 2013 Sep; 338(1):1-2. PubMed ID: 23583678
    [No Abstract]   [Full Text] [Related]  

  • 6. Roles for growth factors and mutations in metastatic dissemination.
    Nataraj NB; Marrocco I; Yarden Y
    Biochem Soc Trans; 2021 Jun; 49(3):1409-1423. PubMed ID: 34100888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer cell plasticity: Impact on tumor progression and therapy response.
    da Silva-Diz V; Lorenzo-Sanz L; Bernat-Peguera A; Lopez-Cerda M; Muñoz P
    Semin Cancer Biol; 2018 Dec; 53():48-58. PubMed ID: 30130663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
    Garg M
    Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasis.
    Romano S; Tufano M; D'Arrigo P; Vigorito V; Russo S; Romano MF
    Semin Cancer Biol; 2020 Feb; 60():181-190. PubMed ID: 31422157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and cancer stem cells.
    Shigdar S; Li Y; Bhattacharya S; O'Connor M; Pu C; Lin J; Wang T; Xiang D; Kong L; Wei MQ; Zhu Y; Zhou S; Duan W
    Cancer Lett; 2014 Apr; 345(2):271-8. PubMed ID: 23941828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells.
    Ceppi P; Peter ME
    Oncogene; 2014 Jan; 33(3):269-78. PubMed ID: 23455327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor and its microenvironment: a synergistic interplay.
    Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
    Liao TT; Yang MH
    Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.
    Terry S; Faouzi Zaarour R; Hassan Venkatesh G; Francis A; El-Sayed W; Buart S; Bravo P; Thiery J; Chouaib S
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy in cancer metastasis.
    Mowers EE; Sharifi MN; Macleod KF
    Oncogene; 2017 Mar; 36(12):1619-1630. PubMed ID: 27593926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.
    Sun B; Zhang D; Zhao N; Zhao X
    Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay of Immunometabolism and Epithelial-Mesenchymal Transition in the Tumor Microenvironment.
    Chou MY; Yang MH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Du B; Shim JS
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.